BERTHA CAMPOS: Open Payments
NPI 1255436366 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 40 payments from 13 companies in 2025. Trend: 2023 $802 · 2024 $984 · 2025 $1,103
Food & beverage: $1,103
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $258 |
| Amgen Inc. | 8 | $223 |
| Lilly USA, LLC | 5 | $186 |
| PFIZER INC. | 5 | $122 |
| Novo Nordisk Inc | 4 | $80 |
| Exact Sciences Corporation | 3 | $46 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Abbott Laboratories | 2 | $34 |
| SANOFI PASTEUR INC. | 1 | $24 |
Products named: REPATHA, AIRSUPRA, BREZTRI, OTEZLA, NURTEC ODT, JARDIANCE, PREVNAR 20, SYNTHROID.
Industry payments across TX — which companies pay providers there.
